Header cover image

Taiwanese Healthcare Buy the Dip

UPDATED Jul 03, 2022

Companies which may present a buying opportunity after a dip in share price.

6 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
4171GeneReach BiotechnologyNT$84.20-11.4%-37.6%NT$3.5bn/aPE9.2xn/a4.1%
4735AViTANT$31.35-9.9%-59.1%NT$1.2bn/aPE7.2xn/a19.8%
6797Taiwan Advanced NanotechNT$119.50-7.4%-38.0%NT$3.6bn/aPE5.5xn/a3.9%
3118Level BiotechnologyNT$26.60-4.0%-14.9%NT$863.2mn/aPE14.2xn/a7.1%
4745Cowealth Medical HoldingNT$23.50-9.3%-13.9%NT$1.8bNT$27.00PE12.8xn/a6.4%
3373Radiant InnovationNT$19.40-17.8%-72.3%NT$839.8mn/aPE16.6xn/a7.7%
Page 1 of 1